Document is current
Any future updates will be listed below
-
Authors
Patel, Nihil
Celaya, Adrian
Eltaher, Mohamed
Glenn, Rachel
Savannah, Kari Brewer
Brock, Kristy K.
Sanchez, Jessica I.
Calderone, Tiffany L.
Cleere, Darrel
Elsaiey, Ahmed
Cagley, Matthew
Gupta, Nakul
Victor, David
Beretta, Laura
Koay, Eugene J.
Netherton, Tucker J.
Fuentes, David T.
-
Funding
Funding for this research was provided by:
Tumor Measurement Initiative
QIAC Partnership in Research (QPR) Program
National Institutes of Health (R01CA195524, R01CA221971, P30CA016672, R01CA195524, R01CA221971, P30CA016672, R01CA195524, R01CA221971, P30CA016672, R01CA195524, R01CA221971, P30CA016672, R01CA195524, R01CA221971, P30CA016672, R01CA195524, R01CA221971, P30CA016672, R01CA195524, R01CA221971, P30CA016672, R01CA195524, R01CA221971, P30CA016672, R01CA195524, R01CA221971, P30CA016672, R01CA195524, R01CA221971, P30CA016672, R01CA195524, R01CA221971, P30CA016672, Loan Repayment Program Award, R01CA195524, R01CA221971, P30CA016672)
National Science Foundation (NSF-2111147, NSF-2111147)
- License Information
-
More Information
Article History
Received: 12 April 2024
Accepted: 29 August 2024
First Online: 9 September 2024
Competing interests
: The authors declare no competing interests.
: Data collection and analysis in this study was approved under Institutional Review Board (IRB) protocols PA13-0317, Comprehensive study of human hepatocellular carcinoma and PA14-0646, Biophysical markers of patients with pancreatic and hepatobiliary cancer. Consent form was waived due to the retrospective nature of the study. All experiments were carried out in accordance with institutional policies.
